Anti-human immunodeficiency virus type 1 activities of dideoxynucleoside phosphotriester derivatives in primary monocytes/macrophages

Research in Virology

Volumn 147, Issue 2-3, 1996, Pages 155-163

  Thumann Schweitzer, C ^a   Gosselin, G ^b   Perigaud C ^b   Benzaria, S ^b   Girardet, J L ^b   Lefebvre, I ^b   Imbach, J L ^b   Kirn, A ^a   Aubertin, A M ^a  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

AIDS; Antiviral activity; Dideoxynucleoside; HIV; Macrophage; Phosphodiester derivatives; Prodrug; SATE substitutes

Indexed keywords

2',3' DIDEOXYADENOSINE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; DIDANOSINE; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0029874098     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2516(96)80230-5     Document Type: Conference Paper

References (49)

1. Arner, E.S.J., Spasokoukotskaja, T. & Eriksson, S. (1992a), Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem. Biophys. Res. Commun., 188, 712-718.
2. Arner, E.S.J., Valentin, A. & Eriksson, S. (1992b), Thymidine and 3′-azido-3′-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. J. Biol. Chem., 267, 10968-10975.
3. Arner, E.S.J. (1994), Salvage and catabolism of pyrimidine deoxyribonucleosides in monocyte-derived macrophages as compared to mitogen-stimulated peripheral blood mononuclear cells. Int. Antiviral News, 2, 67-69.
4. Baba, M., Pauwels, R., Herdewijn, P., De Clercq, E., Desmyter, J. & Vandeputte, M. (1987), Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochem. Biophys. Res. Commun., 142, 128-134.
5. Beenhouwer, D.O., Rankin, J.A. & Mellors, J.W. (1992), Anti-HIV-1 activity of 3′-azido-3′-deoxythimidine (AZT) in primary mononuclear phagocytes. Antivir. Res., 19, 43-54.
6. Benzaria, S., Girardet, J.L., Perigaud, C., Aubertin, A.M., Pelicano, H., Maury, G., Gosselin, G., Kirn, A. & Imbach, J.L. (1994), The SATE pronucleotide derivative of ddA : a more potent HIV inhibitor than AZT. Nucleic Acids Res., 31, 129-130.
7. Chou, J. & Chou, T.C. (1985), Dose-effect analysis with microcomputer: quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor binding and enzyme kinetics. Computer software for Apple II series and IBM-PC and instruction manual, pp. 19-28. Elsevier-Biosoft, Elsevier Science publishers, Cambridge, U.K.
8. Faulds, D. & Brogden, R.N. (1992), Didanosine: a review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs, 44, 94-116.
9. Gao, W.Y., Cara, A., Gallo, R.C. & Lori, F. (1993a), Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. USA, 90, 8925-8928.
10. Gao, W.Y., Shirasaka, T., Johns, D.J., Broder, S. & Mitsuya, H. (1993b), Differential phosphorylation of azidothymidine, dideoxycytidine and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J. Clin. Invest., 91, 2326-2333.
11. Gao, W.Y., Agbaria, R., Driscoll, J.S. & Mitsuya, H. (1994), Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J. Biol. Chem., 267, 12633-12638.
12. Gartner, S., Markovits, P., Markovitz, D.M., Kaplan, M.H., Gallo, R.C. & Popovic, M. (1986), The role of mononuclear phagocytes in HTLV-III/LAV infection. Science, 233, 215-219.
13. Gendelman, H.E., Orenstein, J.M., Baca, L.M., Weiser, B., Burger, H., Kalter, D.C. & Meltzer, M.S. (1989), The macrophage in the persistence and pathogenesis of HIV infection. AIDS, 3, 475-495.
14. Girardet, J.L., Perigaud, C., Aubertin, A.M., Gosselin, G., Kirn, A. & Imbach, J.L. (1995), Increase of the anti-HIV activity of d4T in human T-cell culture by the use of the SATE pronucleotide approach. Bioorg. Med. Chem. Lett. (in press).
15. Hamamoto, Y., Nakashima, H., Matsui, T., Matsuda, A., Ueda, T. & Yamamoto, N. (1987), Inhibitory effect of 2′,3′-dihehydro-2′,3′-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus. Antimicrob. Agents Chemother., 31, 907-910.
16. Hao, Z., Cooney, D.A., Hartman, N.R., Perno, C.F., Fridland, A., DeVico, A.L., Sarngadharan, M.G., Broder, S. & Johns, D.G. (1988), Factors determining the activity of 2′,3′-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Mol. Pharmacol., 34, 431-435.
17. Hao, Z., Cooney, D.A., Farquhar, D., Perno, C.F., Zhang, K., Masood, R., Wilson, Y., Hartman, N.R., Balzarini, J. & Johns, D.G. (1990), Potent DNA chain termination activity and selective inhibition of human immunodeficiency virus reverse transcriptase by 2′,3′-dideoxyuridine-5′-triphosphate. Mol. Pharmacol, 37, 157-163.
18. Ho, H.T. & Hitchcock, M.J.M. (1989), Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother., 33, 844-849.
19. Jacobsson, B., Britton, S., He, Q., Karlsson, A. & Eriksson, S. (1995), Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res. Hum. Retroviruses, 11, 805-811.
20. Johnson, M.A. & Fridland, A. (1989), Phosphorylation of 2′,3′-dideoxyinosine by cytosolic 5′-nucleotidase in human lymphoid cells. Mol. Pharmacol., 36, 291-295.
21. Jones, R.J. & Bischofberger, N. (1995), Minireview: nucleotide prodrugs. Antivir. Res., 27, 1-17.
22. Koenig, S., Gendelman, H.E., Orenstein, J.M., Dal Canto, M.C., Pezeshkpour, G.H., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M.A. & Fauci, A. (1986), Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science, 233, 1089-1093.
23. Lefebvre, I., Perigaud, C., Pompon, A., Aubertin, A.M., Girardet, J.L., Kirn, A., Gosselin, G. & Imbach, J.L. (1995), Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3′-azido-2′,3′-dideoxythymidine 5′-monophosphate. J. Med. Chem., 38, 3941-3950.
24. Lin, T.S., Schinazi, R.F. & Prusoff, W.H. (1987), Potent and selective in vitro activity of 3′-deoxythymidin-2′-ene (3′-deoxy-2′,3′-didehydrothymidine) against human immunodeficiency virus. Biochem. Pharmacol., 36, 2713-2718.
25. McLaren, C., Datema, R., Knupp, C.A. & Buroker, R.A. (1991), Review: Didanosine. Antivir. Chem. Chemother., 2, 321-328.
26. Magnani, M., Casabianca, A., Rossi, L., Fraternale, A., Brandi, G., Silvotti, L. & Piedimonte, G. (1995), Inhibition of HIV-1 and LP-BM5 replication in macrophages by dideoxycytidine and dideoxycytidine 5′-triphosphate. Antivir. Chem. Chemother., 6, 312-319.
27. Mazzulli, T. & Hirsch, M.S. (1992), Combination therapy for HTV-1 infection, in "New directions in antiviral therapy" (Mills J. Corey L. eds) (pp. 385-416). Elsevier, New York.
28. Meltzer, M.S., Nakamura, M., Hansen, B.D., Turpin, J.A., Kalter, D.C. & Gendelman, H.E. (1990), Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Human Retroviruses, 6, 967-971.
29. Mitsuya, H., Weinhold, K.J., Furman, P.A., St Clair, M.H., Nusinoff Lehrman, S., Gallo, R.C., Bolognesi, D., Barry, D.W. & Broder, S. (1985), 3′-azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA, 82, 7096-7100.
30. Mitsuya, H. & Broder, S. (1986), Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2′3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA, 83, 1911-1915.
31. Meyerhans, A., Vartanian, J.P., Hultgren, C., Plikat, U., Karlsson, A., Wang, L., Eriksson, S. & Wain-Hobson, S. (1994), Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J. Virol., 68, 535-540.
32. Munch-Petersen, B., Cloos, L., Tyrsted, G. & Eriksson, S. (1991), Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol Chem., 266, 9032-9038.
33. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J. & De Clercq, E. (1988), Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods, 20, 309-321.
34. Perigaud, C., Gosselin, G., Lefebvre, I., Girardet, J.L., Benzaria, S., Barber, I. & Imbach, J.L. (1993), Rational design for cytosolic delivery of nucleoside monophosphates: "SATE" and "DTE" as enzyme-labile transient phosphate-protecting groups. Bioorg. Med. Chem. Lett., 3, 2521-2526.
35. Perigaud, C., Aubertin, A.M., Benzaria, S., Pelicano, H., Girardet, J.L., Maury, G., Gosselin, G., Kirn, A. & Imbach, J.L. (1994), Equal inhibition of the replication of human immunodeficiency virus in human T-cell culture by ddA bis(SATE) phosphotriester and 3′-azido-2′3′-dideoxythymidine. Biochem. Pharmacol, 48, 11-14.
36. Perigaud, C., Girardet, J.L., Gosselin, G. & Imbach, J.L. (1995), Comments on nucleotide delivery forms, in "Advances hi antiviral drug design" (De Clercq, E., Ed) (Vol. 2), (in press).
37. Ba-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′3′-dideoxynucleosides. J. Exp. Med., 168, 1111-1125.
38. Perno, C.F., Yarchoan, R., Cooney, D.A., Hartman, N.R., Webb, D.S.A., Hao, Z., Mitsuya, H., Johns, D.G. & Broder, S. (1989), Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J. Exp. Med., 169, 933-951.
39. Perno, C.F., Cooney, D.A., Currens, M.J., Rocchi, G., Johns, D.G., Broder, S. & Yarchoan, R. (1990), Ability of anti-HTV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. AIDS Res. Hum. Retroviruses, 6, 1051-1055.
40. Perno, C.F., Cooney, D.A., Gao, W.Y., Hao, Z., Johns, D.G., Foli, A., Hartman, N.R., Calio, R., Broder, S. & Yarchoan, R. (1992), Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood, 80, 995-1003.
41. Perno, C.F. & Calio, R. (1994), Evaluation of anti-HIV compounds in monocyte/macrophages: importance and clinical implications. Int. Antivir. News, 2, 88-89.
42. Puech, F., Gosselin, G., Lefebvre, I., Pompon, A., Aubertin, A.M., Kirn, A. & Imbach, J.L. (1993), Intracellular delivery of nucleoside monophosphates through a reductase-mediated activation process. Antivir. Res., 22, 155-174.
43. Richman, D.D., Kornbluth, R.S. & Carson, D.A. (1987), Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages. J. Exp. Med., 166, 1144-1149.
44. Riddler, S.A., Anderson, R.E. & Mellors, J.W. (1995), Antiretroviral activity of stavudine (2′3′-didehydro-3′-deoxythimidine, D4T). Antivir. Res., 27, 189-203.
45. Rusconi, S., Merill, D.P. & Hirsch, M.S. (1994), Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy. J. Infect. Dis., 170, 1361-1366.
46. Schott, H., Häussler, M.P., Gowland, P., Bender, A., von Briesen, H. & Schwendener, R.A. (1995), Synthesis and in vitro antiviral properties of amphiphilic dinucleoside phosphate derivatives of 2′3′-dideoxycytidine (ddC). Antivir. Chem. Chemother., 6, 320-326.
47. Shelton, M.J., O'Donnell, A.M. & Morse, G.D. (1992), Didanosine. Ann. Pharmacotherapy, 26, 660-670.
48. Shirasaka, T., Chokekijchal, S., Yamada, A., Gosselin, G., Imbach, J.L. & Mitsuya, H. (1995), Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrob. Agents Chemother., 39, 2555-2559.
49. Zelphati, O., Degols, G., Loughrey, H., Leserman, L., Pompon, A., Puech, F., Maggio, A.F., Imbach, J.L. & Gosselin, G. (1993), Inhibition of HIV-1 replication in cultured cells with phosphorylated dideoxyuridine derivatives encapsulated in immunoliposomes. Antivir. Res., 21, 181-195.